Rocket Lab (NASDAQ:RKLB) Price Target Raised to $122.00

Rocket Lab (NASDAQ:RKLB) had its price target increased by Cantor Fitzgerald from $96.00 to $122.00 in a research note released on Tuesday morning, Marketbeat Ratings reports. The firm currently has an overweight rating on the rocket manufacturer’s stock.

Several other equities analysts also recently commented on the stock. Citigroup restated a “market outperform” rating on shares of Rocket Lab in a research note on Tuesday, July 28th. Citizens Jmp increased their price objective on Rocket Lab from $95.00 to $130.00 and gave the company a “market outperform” rating in a research note on Tuesday, June 30th. TD Cowen lifted their target price on Rocket Lab from $90.00 to $120.00 and gave the company a “buy” rating in a report on Friday, May 8th. Craig Hallum lifted their target price on Rocket Lab from $98.00 to $120.00 and gave the company a “buy” rating in a report on Monday, June 29th. Finally, Piper Sandler began coverage on Rocket Lab in a research note on Wednesday, July 15th. They set a “neutral” rating and a $83.00 target price for the company. Three equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Rocket Lab presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.65.

Rocket Lab Trading Down 1.3%

NASDAQ RKLB opened at $80.10 on Tuesday. The firm has a 50 day simple moving average of $85.69 and a 200-day simple moving average of $85.52. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.02 and a current ratio of 4.47. Rocket Lab has a one year low of $37.57 and a one year high of $151.00. The firm has a market cap of $46.36 billion, a price-to-earnings ratio of -296.66 and a beta of 2.60.

Rocket Lab (NASDAQ:RKLB) last announced its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 8.09%. The business had revenue of $234.07 million during the quarter, compared to analyst estimates of $231.62 million. Equities research analysts anticipate that Rocket Lab will post -0.26 EPS for the current fiscal year.

Insider Activity at Rocket Lab

In other Rocket Lab news, SVP Arjun Kampani sold 88,000 shares of the stock in a transaction that occurred on Thursday, June 18th. The shares were sold at an average price of $107.98, for a total value of $9,502,240.00. Following the sale, the senior vice president directly owned 264,705 shares of the company’s stock, valued at approximately $28,582,845.90. This represents a 24.95% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Alexander R. Slusky sold 60,000 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $149.40, for a total transaction of $8,964,000.00. Following the completion of the sale, the director owned 374,675 shares in the company, valued at $55,976,445. The trade was a 13.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 3,749,294 shares of company stock worth $351,008,208 over the last ninety days. 8.40% of the stock is currently owned by insiders.

Institutional Trading of Rocket Lab

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in shares of Rocket Lab by 13.4% during the 4th quarter. Vanguard Group Inc. now owns 47,420,192 shares of the rocket manufacturer’s stock worth $3,308,033,000 after acquiring an additional 5,610,469 shares in the last quarter. BlackRock Inc. purchased a new stake in Rocket Lab during the second quarter worth approximately $4,124,970,000. Capital World Investors boosted its holdings in Rocket Lab by 12.0% in the fourth quarter. Capital World Investors now owns 16,200,726 shares of the rocket manufacturer’s stock valued at $1,130,172,000 after purchasing an additional 1,738,623 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Rocket Lab in the second quarter valued at approximately $245,764,000. Finally, State Street Corp increased its stake in Rocket Lab by 1.0% in the fourth quarter. State Street Corp now owns 12,520,223 shares of the rocket manufacturer’s stock valued at $873,411,000 after purchasing an additional 120,652 shares during the last quarter. 71.78% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab said the U.S. Hart-Scott-Rodino antitrust waiting period for its Iridium acquisition has lapsed, clearing a significant regulatory hurdle. The company also filed its Form S-4 and FCC applications, moving the transaction forward. Rocket Lab Corporation Announces Progress on Iridium Acquisition
• Positive Sentiment: Rocket Lab reported a record backlog approaching $2.4 billion and quarterly revenue of $234.1 million, above analyst expectations. Strong demand across its space-systems business supports the long-term growth story. Rocket Lab’s Backlog Just Hit $2.4 Billion
• Neutral Sentiment: The company expects Neutron’s first launch in the fourth quarter, but management did not provide a specific date. Because part of the backlog depends on Neutron, successful development and launch execution remain important catalysts—and significant risks. Rocket Lab’s Backlog Just Hit $2.4 Billion. Here’s Why Neutron’s First Flight Matters More
• Negative Sentiment: Rocket Lab authorized a replacement at-the-market equity program of up to approximately $1.94 billion. Although it replaces only the unsold amount under the previous agreement, selling shares to fund the Iridium purchase and reduce debt commitments could pressure the stock through dilution. Rocket Lab Announces Dollar-for-Dollar Replacement At-The-Market Equity Program
• Negative Sentiment: The Iridium transaction still involves substantial financing, including plans related to a $3.6 billion bridge facility. Investors remain concerned about leverage, execution risk and the valuation of the deal, despite the strategic expansion it could provide. Rocket Lab $3.6 Billion Financing Plan Takes Shape
• Negative Sentiment: Rocket Lab’s latest quarterly loss was wider than expected, with EPS of negative $0.08 versus consensus of negative $0.06. The company remains unprofitable, and concerns about a possible Neutron delay contributed to the post-earnings pullback. Rocket Lab’s Highly Anticipated Neutron Flight May Be Delayed

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.